| Date | Name | Shares | Transaction | Value |
|
Feb 28, 2025
| Raymond W. Chang VP and General Counsel |
319,944
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 28, 2025
| David A. Cherechinsky President and CEO; Director |
958,238
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 28, 2025
| Mark Johnson See remarks |
228,075
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 28, 2025
| Kelly T Munson See Remarks |
142,925
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 28, 2025
| Fanny R Surratt See Remarks |
59,572
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 26, 2025
| Raymond W. Chang VP and General Counsel |
316,854
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 26, 2025
| Raymond W. Chang VP and General Counsel |
295,527
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $17.43 per share |
5,151,035.61
|
|
Feb 26, 2025
| David A. Cherechinsky President and CEO; Director |
921,737
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 26, 2025
| David A. Cherechinsky President and CEO; Director |
836,818
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $17.43 per share |
14,585,737.74
|
|
Feb 26, 2025
| Mark Johnson See remarks |
214,501
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 26, 2025
| Mark Johnson See remarks |
194,685
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $17.43 per share |
3,393,359.55
|
|
Feb 26, 2025
| Kelly T Munson See Remarks |
139,338
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 26, 2025
| Kelly T Munson See Remarks |
125,183
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $17.43 per share |
2,181,939.69
|
|
Feb 26, 2025
| Fanny R Surratt See Remarks |
57,777
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 26, 2025
| Fanny R Surratt See Remarks |
50,699
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $17.43 per share |
883,683.57
|